+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma



DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma



Human Pathology. 27(7): 676-682



DNA flow cytometry and the monoclonal antibody DO7 were applied in formalin-fixed, paraffin-embedded specimens from 34 primary male breast carcinomas to verify whether DNA ploidy and p53 expression were associated with survival and proliferative activity. They were compared with tumor clinicopathologic features, sex steroid hormone receptors and cell proliferative activity, assessed by the counts of the argyrophilic nucleolar organizer regions (AgNORs), the monoclonal antibody PC10 against the proliferating cell nuclear antigen and the monoclonal antibody MIB-1. A significant correlation was found between survival and tumor ploidy (median survival, 77 months for diploid but only 38 months for aneuploid cases; P = .03) and p53 expression (median survival, 95 months for cases with p53 scores < or = 14.06% versus 33 for cases with P53 scores > 14.06%; P = .0004; median survival, 99 months for p53 negative vs 39 for positive cases; P = .007). Tumor histological grade (P = .006), AgNOR counts (P = .0001), PC10 scores (P = .002), and MIB-1 scores (P = .001) were also associated with prognosis. In the multivariate analysis, only p53 scores (P = .001) or p53 immunopositivity (P = .003) and AgNOR counts (P = .022) retained an independent prognostic significance. Aneuploid tumors had higher AgNOR counts (P = .002), PC10 (P = .007), MIB-1 (P = .006), and p53 scores (P = .01) than diploid cases. A linear relationship was observed between p53 scores and AgNOR counts (r = .41; P = .014), PC10 (r = .46; P = .005), and MIB-1 scores (r = .44; P = .011). These results indicate that DNA ploidy and p53 expression are associated with survival and cell proliferative activity in male breast carcinoma. Quantitative parameters, such as DNA ploidy, p53 scores, AgNOR counts, PC10, and MIB-1 scores substantially improve the prognostic significance of the traditional parameters in male breast carcinoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008416660

Download citation: RISBibTeXText

PMID: 8698311

DOI: 10.1016/s0046-8177(96)90397-4


Related references

In male breast carcinoma DNA flowcytometric ploidy correlates with proliferative activity and prognosis. Pathology Research & Practice 191(7-8): 754, 1995

High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors. Cancer 94(9): 2454-2465, 2002

Nuclear morphometry in male breast carcinoma: Association with cell proliferative activity, oncogene expression, DNA content and prognosis. International Journal of Cancer 89(6): 494-499, 20 November, 2000

Evaluation of DNA-ploidy, proliferative activity expression of some cell proteins and estrogen receptor content in primary breast cancers. Pathology Research & Practice 191(7-8): 740, 1995

Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma. European Urology 15(3-4): 271-276, 1988

Comparative study of proliferative activity and DNA ploidy in esophageal spindle cell squamous carcinoma. Modern Pathology 8(1): 64A, 1995

The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique. Cancer 74(6): 1739-1745, 1994

Spindle cell squamous carcinoma of the esophagus: analysis of ploidy and tumor proliferative activity in a series of 13 cases. Human Pathology 29(8): 863-868, 1998

Angiogenesis, Proliferative Activity and DNA Ploidy in Oral Verrucous Carcinoma: A Comparative Study Including Verrucous Hyperplasia and Squamous Cell Carcinoma. Pathology Oncology Research 21(4): 1249-1257, 2016

Proliferative activity is a significant prognostic factor in male breast carcinoma. American Journal of Pathology 145(2): 481-489, 1994

Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma. International Journal of Cancer 42(5): 703-708, 1988

The impact of dna ploidy and proliferative index on survival of breast cancer patients. Mie Medical Journal 38(2): 111-124, 1988